Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01227330|
Recruitment Status : Completed
First Posted : October 25, 2010
Last Update Posted : October 24, 2016
|Condition or disease||Intervention/treatment||Phase|
|Hypercholesterolemia Medication Adherence||Behavioral: Medication adherence intervention Behavioral: Attention-control||Phase 1 Phase 2|
This study will answer the following primary research question:
What is the estimated effect size of a behavioral MA intervention on MA rates in older adults who are poorly adherent to statin medications?
The study will also explore the following secondary research questions:
- What is the estimated effect size of a behavioral MA intervention on low-density lipoprotein cholesterol (LDL-C) levels in older adults?
- What is the estimated effect size of a behavioral MA intervention on high-density lipoprotein cholesterol (HDL-C) levels in older adults?
- What is the feasibility of successfully testing this intervention protocol in a population of older adults with low adherence to statin medications?
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||43 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults|
|Study Start Date :||October 2010|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||February 2014|
Experimental: Medication adherence intervention
Receives 12-week behavioral feedback intervention to improve adherence to statin medication
Behavioral: Medication adherence intervention
12-week behavioral feedback intervention to improve adherence to statin medication
No Intervention: Control
Active Comparator: Attention-control
Receives visits on the same schedule as the intervention group, with health education that is unrelated to medications or cholesterol
Health education visits that are unrelated to medications or cholesterol, provided on the same visit schedule as the intervention group
- Medication adherence [ Time Frame: 6 months ]
- Serum cholesterol [ Time Frame: 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01227330
|United States, Missouri|
|University of Missouri|
|Columbia, Missouri, United States, 65211|
|Principal Investigator:||Todd Ruppar, PhD, RN||University of Missouri-Columbia|